Quantcast
Last updated on April 20, 2014 at 7:54 EDT

Latest Alkaloids Stories

Experimental Cocaine Vaccine Effective On Mice, Primates
2013-05-11 09:39:58

Brett Smith for redOrbit.com — Your Universe Online Although trends are pointing to a decrease in recent years, cocaine use is still a major problem in the US, with 1.5 million users in 2010 — according to the Substance Abuse and Mental Health Services Administration (SAMHSA). To combat this highly addictive illegal drug, researchers at Weill Cornell Medical College are developing an “anti-cocaine vaccine” designed to keep the drug from creating the...

2013-05-09 23:01:11

Cocaine provides short-term high but long-term problems for adults and children. Recovery Associates provides clinical and therapeutic aid toward stopping its use with their cocaine addiction treatment and rehab services. (PRWEB) May 09, 2013 Cocaine abuse remains problematic for adults and children alike across the United States, leaving them in precarious health situations. Research provided by the National Institute on Drug Abuse indicates that cocaine is a powerfully addictive stimulant...

2013-05-06 08:31:08

BUFFALO, N.Y., May 6, 2013 /PRNewswire/ -- Kinex Pharmaceuticals and Zenith Technology Corporation, through its affiliate ZenRx, announced today the execution of a collaborative licensing agreement granting Zenith Technology commercial rights to Oraxol and Oratecan in New Zealand and Australia. ZenRx will provide an upfront payment, milestones and royalties. Importantly, Zenith Technology Corporation will commit a significant amount of resources to the Oraxol and Oratecan global development...

2013-04-25 08:35:32

EAST SETAUKET, N.Y., April 25, 2013 /PRNewswire/ -- Lixte Biotechnology Holdings, Inc. (LIXT), reported the start of a Phase I trial to determine the appropriate dose of its potentially first-in-class, anticancer compound, LB-100, when given alone and then when given in combination with docetaxel (Taxotere®). Details of the trial underway at an NCI-designated Comprehensive Cancer Center are available in the clinical trials registry: http://clinicaltrials.gov/show/NCT01837667. Dr. John...

2013-04-10 04:21:07

LAUSANNE, Switzerland and CHENNAI, India, April 10, 2013 /PRNewswire/ -- Shasun Pharmaceuticals Ltd, a global pharmaceutical contracting organization offering world class capabilities and facilities to provide services and manufacturing at every scale across the whole drug development lifecycle and Debiopharm Group(TM) (Debiopharm) a Swiss-based global biopharmaceutical group with a focus on the development of innovative prescription drugs that target unmet medical needs, entered into a...

2013-04-08 00:20:36

IGDRASOL will present updates on its proprietary late clinical stage NBN-Pac formulations, including Cynviloq(TM), a paclitaxel nanoparticle, and the recently acquired IG-004, a vitamin E-based paclitaxel emulsion. Highlights of the findings include the studies and comparison of pharmacokinetic and pharmacodynamic properties as well as drug release characteristics to Abraxane®, an albumin-based paclitaxel nanoparticle (nab-paclitaxel). SAN DIEGO and FOUNTAIN VALLEY, Calif., April...

Lasers May Help Cure Cocaine Addiction
2013-04-05 09:03:05

redOrbit Staff & Wire Reports - Your Universe Online New hope for the estimated 1.4 million Americans addicted to cocaine could come in the form of a laser-inspired treatment that could effectively turn off their craving for the illicit drug, claims research published in this week´s edition of the journal Nature. According to HealthDay News, scientists from the University of California, San Francisco (UCSF) and the US National Institute of Drug Abuse (NIDA) used laser light to...

Genetic Markers For Smoking Predict Risk 032813
2013-03-28 11:19:07

Brett Smith for redOrbit.com - Your Universe Online According to a new study in JAMA Psychiatry, a team of international scientists has developed a genetic profile that indicates a greater risk for a teenager's progression into becoming a lifelong heavy smoker. People who share the genetic profile showed a greater risk of daily smoking as teenagers and then progressing more rapidly to smoking a pack a day or more as adults, the study said. High-risk individuals who were assessed in...

2013-03-19 08:27:35

GLEN ALLEN, Va., March 19, 2013 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI), through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Inc., announced today that it has received positive preliminary results from a study investigating the effects of anatabine in an animal model of idiopathic inflammatory bowel disease, Crohn's disease and ulcerative colitis. This study, performed by researchers in the Department of Medicine at the University of Virginia, assessed the effects...

2013-03-19 08:26:36

-- Clinical Entry Planned for Second Half of 2013 -- SEATTLE, March 19, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has elucidated the mechanism of action of its phosphodiesterase 7 (PDE7) inhibitors in the neural network shown to be responsible for addiction in humans. Omeros believes that it is the first to discover the link between PDE7 and any addiction or compulsive disorder, and the Company is establishing a broad intellectual property...